Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis

NCT02143778 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT02143778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Lead sponsor
Meridian Bioscience, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
January 31, 2019
Enrollment
246 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

patients with compensated liver cirrhosis